Eggehard Holler
Corporate Officer/Principal chez University of Regensburg
Profil
Eggehard Holler is the founder of Arrogene, Inc. which was founded in 2006.
He held the title of Director from 2006 to 2013.
Currently, he is a Professor at the University of Regensburg, a position he has held since 1972.
Dr. Holler earned a doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Postes actifs de Eggehard Holler
| Sociétés | Poste | Début |
|---|---|---|
| University of Regensburg | Corporate Officer/Principal | 01/01/1972 |
Anciens postes connus de Eggehard Holler
| Sociétés | Poste | Fin |
|---|---|---|
Arrogene, Inc.
 Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Fondateur | - |
Formation de Eggehard Holler
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Arrogene, Inc.
Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Health Technology |